HAZLETT, BURT & WATSON, INC.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 46392 WHEELING, WV

Position in HALO

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$3,130

+$3,127 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#611

of 661 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HAZLETT, BURT & WATSON, INC. holds $93,894 across 5 Biotechnology names. HALO ranks #3 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FTRE	Fortrea Holdings Inc.	4,672	$81,292
2	REGN	Regeneron Pharmaceuticals, Inc.	14	$8,729
3	HALO	Halozyme Therapeutics, Inc. This page	40	$3,130
4	IOVA	Iovance Biotherapeutics, Inc.	100	$416
5	CRSP	CRISPR Therapeutics AG	6	$327

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,130	40	0.0%	Shares	Sole	2026-07-30
2026-03-31	$3	40	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.